In the comparison between patients with early-stage p16-negative OPSCC and healthy controls, 103 proteins were presented in the S-plot (p(corr) ± 0.80), and 104 proteins were presented in the comparison of p16-positive tumours versus controls, respectively (Supplementary Figures 7 and 8). The gene discussed is CDKN2A; the disease is neoplasm.